Almost 50 million people are living with dementia in 2018 worldwide, and the number will
double every 20 years. The effectiveness of existing pharmacologic treatments for the …

This paper presents some preliminary results of the OPLON project. It aimed at identifying
early linguistic symptoms of cognitive decline in the elderly. This pilot study was conducted …

Background: The discovery of early, non-invasive biomarkers for the identification of
“preclinical” or “pre-symptomatic” Alzheimer's disease and other dementias is a key issue in …

It is estimated that between 50% and 75% of all cases of dementia are due to Alzheimer's
disease (AD), the most common neurodegenerative disease among World population …

This study aimed at evaluating whether people with a normal cognitive function can be
discriminated from subjects with a mild impairment of cognitive function based on a set of …

Background: Even today the reliable diagnosis of the prodromal stages of Alzheimer's
disease (AD) remains a great challenge. Our research focuses on the earliest detectable …

Alzheimer's disease (AD) is a neurodegenerative disorder that develops for years before
clinical manifestation, while mild cognitive impairment is clinically considered as a …

Here we seek to automatically identify Hungarian patients suffering from mild cognitive
impairment (MCI) based on linguistic features collected from their speech transcripts. Our …

The World Health Organization estimates that 50 million people are currently living with
dementia worldwide and this figure will almost triple by 2050. Current pharmacological …

Background: Various types of dementia and Mild Cognitive Impairment (MCI) are manifested
as irregularities in human speech and language, which have proven to be strong predictors …